Eris Lifesciences Ltd. has 5,665 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 7.4%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model. Ranked #21 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 16 years from inception. Eris is also successfully diversifying its business with 3 emerging therapies (Dermatology, Neuropsychiatry and Gynaecology) accounting for 26% of its revenue. We began our journey 16 years ago in 2007 with the vision to make a meaningful impact in the management of chronic lifestyle related diseases. Today Chronic and Sub-chronic therapies account for ~ 87% of our revenue, and our product range spans ~ 90% of India’s Rs. 55,000+ crore chronic care market. Our business model is pivoted around specialist/ super specialist doctors and high end consulting physicians. We consistently endeavour to channel the advantages of cutting-edge medical knowledge to aid our clinicians and patients with better disease management options and outcomes
As of September 2025
Eris Lifesciences
workforce metrics
Headcount
5.7k
Avg. Salary
$12.2k
Tenure
3.3yr
Growth Rate
7.4%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Eris Lifesciences annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Eris Lifesciences annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?